| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Antares Pharma Inc (NASDAQ: ATRS)
ATRS Technical Analysis
5
| As on 24th May 2022 ATRS STOCK Price closed @ 5.59 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.05 & Strong Buy for SHORT-TERM with Stoploss of 4.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATRSSTOCK Price
| Open | 5.59 | Change | Price | % |
| High | 5.59 | 1 Day | 0.00 | 0.00 |
| Low | 5.59 | 1 Week | 0.02 | 0.36 |
| Close | 5.59 | 1 Month | 1.55 | 38.37 |
| Volume | N/A | 1 Year | 2.15 | 62.50 |
| 52 Week High 5.59 | 52 Week Low 3.15 | ||||
NASDAQ USA Most Active Stocks
| PSTV | 0.32 | 68.42% |
| AMRS | 0.14 | 100.00% |
| GNLN | 0.01 | 0.00% |
| NVDA | 154.31 | 4.33% |
| HCTI | 0.03 | 0.00% |
| VOR | 0.55 | 71.88% |
| LMDX | 0.02 | 0.00% |
| TSLA | 327.55 | -3.79% |
| LCID | 2.14 | -1.38% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATRS Daily Charts |
ATRS Intraday Charts |
Whats New @ Bazaartrend |
ATRS Free Analysis |
|
|
ATRS Important Levels Intraday
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.59 |
ATRS Forecast June 2025
| 4th UP Forecast | 7.34 |
| 3rd UP Forecast | 6.78 |
| 2nd UP Forecast | 6.43 |
| 1st UP Forecast | 6.09 |
| 1st DOWN Forecast | 5.09 |
| 2nd DOWN Forecast | 4.75 |
| 3rd DOWN Forecast | 4.4 |
| 4th DOWN Forecast | 3.84 |
ATRS Weekly Forecast
| 4th UP Forecast | 7.07 |
| 3rd UP Forecast | 6.60 |
| 2nd UP Forecast | 6.30 |
| 1st UP Forecast | 6.01 |
| 1st DOWN Forecast | 5.17 |
| 2nd DOWN Forecast | 4.88 |
| 3rd DOWN Forecast | 4.58 |
| 4th DOWN Forecast | 4.11 |
ATRS Forecast2025
| 4th UP Forecast | 10.39 |
| 3rd UP Forecast | 8.85 |
| 2nd UP Forecast | 7.9 |
| 1st UP Forecast | 6.95 |
| 1st DOWN Forecast | 4.23 |
| 2nd DOWN Forecast | 3.28 |
| 3rd DOWN Forecast | 2.33 |
| 4th DOWN Forecast | 0.79 |
Antares Pharma Inc ( NASDAQ USA Symbol : ATRS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATRS Business Profile
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas. It develops, manufactures, and commercialize novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and for glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto injectors; and drug/device product for urologic oncology and endocrinology. The company have strategic alliances and partnership arrangements pharmaceutical companies, including Pfizer, Idorsia, Teva, and AMAG. Antares Pharma, Inc. was founded in 1978 and is headquartered in Ewing, New Jersey. Address: 100 Princeton South, Ewing, NJ, United States, 08628
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service